secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avalon GloboCare Corp. (ALBT)
CIK:        0001630212
Form:       8-K
Filed at:   2025-07-14T23:59:59+00:00
Accession:  0001213900-25-063521
Event type: regulatory
Sentiment:  positive
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avalon GloboCare granted Hong Kong patent for CAR-T/CAR-NK cell technology
--------------------------------------------------------------------------

- Hong Kong Intellectual Property Department issued standard patent HK40074322 for CAR-T and CAR-NK cell technology.
- Patent term of 20 years effective February 21, 2020, providing protection through 2040 in Hong Kong.
- Co-developed with strategic partner Arbele Limited; complements existing US and PCT patent protections.
- Technology features bispecific Anti-CD19xCD22 CAR design and localized cytokine induction to enhance efficacy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630212/000121390025063521/0001213900-25-063521-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630212/000121390025063521/ea0248802-8k_avalon.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-063521

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer